Screening for Diabetic Peripheral Neuropathy: Subjective Versus Objective Measures

Area of Science:

• Neurology
• Diabetology
• Medical Devices

Background:

• Diabetic peripheral neuropathy (DPN) is a common complication of diabetes, increasing the risk of foot ulcers and amputations.
• Current diabetic foot screening guidelines often rely on subjective sensory tests.
• The diagnostic accuracy and sensitivity of these subjective tools for DPN detection can vary.

Purpose of the Study:

• To compare the effectiveness of various subjective screening modalities for diabetic peripheral neuropathy (DPN) against an objective measure.
• To evaluate the NC-Stat DPNCheck®, an automated sural nerve conduction test, as an objective tool for DPN screening.
• To assess the sensitivity and diagnostic differences among commonly used subjective DPN screening tools.

Main Methods:

• Sixty-three participants with diabetes were evaluated using multiple subjective screening tools: Semmes-Weinstein 10-g monofilament, 128-Hz traditional tuning fork, neurothesiometer, and O'Brien 128-Hz electronic tuning fork.
• Results from subjective tests were compared with objective measurements obtained from the NC-Stat DPNCheck®.
• Statistical analysis was performed to identify significant differences in DPN classification between the screening methods.

Main Results:

• A statistically significant difference (P < .05) was observed in the number of limbs classified as having DPN across all tested screening modalities.
• This indicates variability in sensitivity among the subjective screening tools for detecting DPN.
• The study highlights potential discrepancies in DPN diagnosis depending on the screening method employed.

Conclusions:

• Subjective screening modalities recommended in diabetic foot screening guidelines exhibit varying sensitivity for DPN detection.
• The findings underscore the importance of utilizing multiple screening tools for a thorough assessment of a patient's neurological status in diabetes.
• Incorporating objective measures, such as the NC-Stat DPNCheck®, into routine diabetic foot screening is recommended, and further research is needed to establish a gold standard diagnostic tool for DPN.